Evolent Health, Inc. reports results for the quarter ended June 30 - Earnings Summary

Evolent Health

06/08/2026 15:16

Evolent Health, Inc. EVH.N reported quarterly adjusted earnings of 2 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -10 cents.  The mean expectation of sixteen analysts for the quarter was for a loss of 2 cents per share. Wall Street expected results to range from -11 cents to 1 cents per share.
Revenue rose 46.9% to $652.52 million from a year ago; analysts expected $598.00 million. 
Evolent Health, Inc.'s reported EPS for the quarter was a loss of 25 cents​.
The company reported a quarterly loss of $28.36 million.
Evolent Health, Inc. shares had fallen by 43.2% this quarter and lost 23.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 25.2% in the last three months.​ 
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy" 
Wall Street's median 12-month price target for Evolent Health, Inc. is $6.00, about 48.7% above its last closing price of $3.08
This summary was machine generated from LSEG data August 6 at 02:16 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.02
0.02
Beat
Mar. 31 2026 
-0.05
-0.02
Beat
Dec. 31 2025 
0.06
0.08
Beat
Sep. 30 2025 
0.10
0.05
Missed